Anti-CD103 antibody [EPR4166]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal CD103 antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
CD103, Integrin alpha-E, HML-1 antigen, Integrin alpha-IEL, Mucosal lymphocyte 1 antigen, ITGAE
- WB
Unknown
Western blot - Anti-CD103 antibody [EPR4166] (AB108503)
All lanes:
Western blot - Anti-CD103 antibody [EPR4166] (ab108503) at 1/1000 dilution
Lane 1:
HuT-78 cell lysate at 10 µg
Lane 2:
Jurkat cell lysate at 10 µg
Lane 3:
A431 cell lysate at 10 µg
Lane 4:
HeLa cell lysate at 10 µg
Lane 5:
K562 cell lysate at 10 µg
Predicted band size: 130 kDa
Observed band size: 150 kDa
false
Related conjugates and formulations (1)
-
Anti-CD103 antibody [EPR4166] - BSA and Azide free
Reactivity data
Product details
Clone EPR4166 is different from clone EPR4166(2).
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD103 is essential for establishing and maintaining interactions between immune cells and epithelial cells. By incorporating into the αEβ7 integrin complex it plays an important role in the localization of intraepithelial lymphocytes and dendritic cells in the gut mucosa and skin contributing to immune surveillance and protection of these barriers. CD103 helps to control lymphocyte activation and the migration process offering a critical surface marker for identifying tissue-resident memory T cells (Trm cells) and discerning their functional potential.
Pathways
CD103 functions prominently in the immunological environment by participating in pathways that regulate lymphocyte adherence and migration. Two significant pathways it fits into include the T-cell homing and retention pathways and the antigen presentation pathway. Through these pathways CD103 interacts with molecules such as E-cadherin and impacts the movement of T cells to epithelial sites influencing tissue-specific immune responses alongside related proteins like integrin beta 7 which forms a part of the same integrin complex.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cell reports 29:3916-3932.e5 PubMed31851923
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of gastrointestinal oncology 10:723-733 PubMed31392053
2019
Applications
Unspecified application
Species
Unspecified reactive species
Diagnostic pathology 11:66 PubMed27457239
2016
Applications
IHC-P
Species
Human
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com